查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1938260

腦植入市場 - 全球產業規模、佔有率、趨勢、機會及預測（按產品類型、應用、最終用戶、地區和競爭格局分類，2021-2031年）

Brain Implants Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Application, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球腦植入市場預計將從 2025 年的 69.8 億美元成長到 2031 年的 127.7 億美元，複合年成長率達到 10.59%。

這些醫療設備植入顱腔內，透過刺激神經通路或記錄電活動，直接與生物神經系統相互作用，進而治療神經系統疾病。推動該市場成長要素包括帕金森氏症、癲癇和憂鬱症嚴重的日益增多，以及全球人口老化導致長期照護需求增加。世界衛生組織的數據顯示，到2024年，全球將有超過30億人受到神經系統疾病的影響，使其成為疾病和殘疾的主要原因之一。

市場概覽
預測期 2027-2031
市場規模：2025年 69.8億美元
市場規模：2031年 127.7億美元
複合年成長率：2026-2031年 10.59%
成長最快的細分市場 深部腦部刺激裝置
最大的市場 北美洲

然而，由於所需手術高成本且具侵入性，該市場面臨許多障礙。這些相關風險往往會阻礙患者接受治療，並增加新設備監管核准流程的複雜性。此外，不同醫療體系嚴格的報銷政策也造成了經濟障礙，限制了這些治療技術的廣泛應用，最終減緩了該行業在全球範圍內的發展。

市場促進因素

神經技術和腦機介面（BCI）領域資本投資的顯著成長正在改變市場格局，為加速臨床試驗和擴大生產規模提供了所需的流動性。企業和創業投資的湧入使各公司能夠在遵守III類醫療設備高昂且複雜的監管要求的同時，推動硬體耐用性和訊號處理技術的快速創新。例如，2025年5月，Semafor報道稱，Neuralink完成了資金籌措，估值約為90億美元，顯示投資者對植入式神經技術的可擴展性充滿信心。這種資金動能與臨床進展相輔相成。 2025年10月，Fierce Biotech發表的研究結果顯示，Science Corp.的PRIMA BCI視網膜植入成功恢復了重度老齡化黃斑部病變患者的部分視力，進一步證實了該領域的治療潛力。

同時，微創神經外科手術需求的不斷成長，透過降低傳統開放性手術的風險和縮短恢復時間，擴大了患者群體。患者和醫療服務提供者都傾向於選擇血管內和微創植入技術，這些技術可以減少感染和腦組織損傷等手術併發症，並提高其應用率。這種轉變正在推動策略性商業化進程。根據 MedTech Dive 2025 年 11 月的報告，Synchron 公司在 D 輪資金籌措中籌集了 2 億美元，為其 Stentrode 系統的上市做準備。本系統無需開顱即可經頸靜脈植入。此類輸送機制的進步對於將腦植入從實驗性治療轉變為治療癱瘓和其他神經系統疾病的實用、普及的醫療解決方案至關重要。

市場挑戰

全球腦植入市場受到高成本和手術創傷性等諸多因素的顯著限制。腦植入通常需要複雜的腦外科手術，例如開顱手術，並伴隨感染疾病、出血和中風等重大健康風險。這些風險，加上植入設備高昂的費用和術後長期照護的需求，構成了很高的進入門檻。因此，患者和醫療機構通常僅在藥物治療無效的嚴重病例中才考慮此類手術，從而縮小了潛在市場。

目前的應用統計數據表明，這種限制顯而易見。根據美國神經外科醫師協會統計，截至2024年，全球已有超過16萬名患者接受了深部腦部刺激術治療各種神經系統疾病。然而，考慮到數百萬患有運動障礙的患者，這項應用率仍然非常低。大量符合資格的患者與有限的醫療服務提供者之間存在著鮮明的對比，這凸顯了經濟和程序方面的挑戰如何有效地阻礙了該領域的廣泛發展。

市場趨勢

直接神經控制技術在言語和運動功能恢復方面的出現，正從根本上改變市場格局，使義肢從簡單的遊標控制發展到能夠快速、自然地進行交流。這一趨勢的驅動力在於複雜的演算法，這些演算法能夠將神經活動轉化為流暢的語言，其速度和準確性堪比自然對話，從而克服了前幾代產品存在的顯著延遲問題。近期一項重要的成果便是對這項技術的展示：根據美聯社2025年4月發表的題為《中風倖存者藉助實驗性腦植入再次開口說話》的報導，一種新型腦機介面系統成功地將一位癱瘓的中風倖存者的神經訊號轉化為語音，其速度約為每分鐘91個單詞，顯著超越了以往的標準。

同時，封閉回路型自適應深部腦部刺激系統的引入，正透過從靜態、連續刺激轉向動態、響應式治療，重新定義運動障礙的治療標準。這些新一代植入採用整合感測技術，監測局部場電位，並即時自動調節電刺激，從而最佳化臨床療效，同時最大限度地減少有害副作用。這種向個人化生物電子醫學的轉變已取得重要的商業性里程碑。根據 MedTech Dive 2025 年 2 月發表的報導《美敦力公司用於帕金森氏症的自適應 DBS 系統獲得 FDA核准》，Medtronic的 BrainSense 自適應 DBS 設備已獲得 FDA核准，成為首個基於檢測到的腦活動而獲得監管部門批准的自適應治療系統。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球腦植入市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依產品類型（深部腦部刺激器、脊髓刺激設備、迷走神經刺激設備）
    • 根據適應症（慢性疼痛、癲癇、帕金森氏症、憂鬱症、自發性震顫、阿茲海默症）
    • 依最終使用者（醫院/診所、門診手術中心、其他）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章 北美腦植入市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲腦植入市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章 亞太地區腦植入市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲腦植入市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章 南美洲腦植入市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球腦植入市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Medtronic plc
  • Boston Scientific Corporation
  • Abbott Laboratories
  • NeuroPace, Inc.
  • LivaNova plc
  • Aleva Neurotherapeutics SA
  • Neuralink Corporation
  • Synchron, Inc.
  • Paradromics Inc.
  • Blackrock Neurotech

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 7304

The Global Brain Implants Market is projected to expand from USD 6.98 Billion in 2025 to USD 12.77 Billion by 2031, achieving a CAGR of 10.59%. These medical devices are implanted within the cranial cavity to interact directly with the biological nervous system, either by stimulating neural pathways or recording electrical activity to treat neurological disorders. The market is primarily driven by the increasing prevalence of debilitating conditions like Parkinson's disease, epilepsy, and depression, as well as an aging global population that needs long-term care. Data from the World Health Organization indicates that in 2024, neurological conditions affected more than 3 billion people worldwide, making them the leading cause of illness and disability globally.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 6.98 Billion
Market Size 2031USD 12.77 Billion
CAGR 2026-203110.59%
Fastest Growing SegmentDeep Brain Stimulators
Largest MarketNorth America

However, the market confronts substantial hurdles due to the high cost and invasive nature of the required surgical procedures. These associated risks frequently discourage patient adoption and add complexity to the regulatory approval process for new devices. Additionally, strict reimbursement policies across various healthcare systems establish financial barriers that limit widespread access to these therapeutic technologies, effectively slowing the overall growth of the global sector.

Market Driver

A significant surge in capital investment within neurotechnology and brain-computer interfaces (BCI) is transforming the market, providing the liquidity needed to accelerate clinical trials and scale manufacturing. This influx of corporate funding and venture capital enables companies to navigate the expensive and complex regulatory requirements for Class III medical devices while driving rapid innovation in hardware durability and signal processing. For example, Semafor reported in May 2025 that Neuralink secured $600 million in a funding round that valued the company at roughly $9 billion, indicating strong investor confidence in the scalability of implantable neural technologies. This financial momentum is matched by clinical progress; Fierce Biotech noted in October 2025 that a study showed Science Corp.'s PRIMA BCI retinal implant successfully restored partial vision in patients with severe age-related macular degeneration, confirming the sector's therapeutic potential.

Simultaneously, the increasing demand for minimally invasive neurosurgical procedures is broadening the addressable patient population by lowering the risks and recovery times linked to traditional craniotomies. Both patients and providers are showing a preference for endovascular and less traumatic insertion methods, which reduce surgical complications like infection and brain tissue damage, thereby improving adoption rates. This shift is fueling strategic commercialization efforts; according to MedTech Dive in November 2025, Synchron raised $200 million in Series D financing to prepare for the market launch of its Stentrode system, a device designed for implantation via the jugular vein without open-brain surgery. Such advancements in delivery mechanisms are essential for transitioning brain implants from experimental treatments to viable, widespread medical solutions for paralysis and other neurological deficits.

Market Challenge

The Global Brain Implants Market is significantly constrained by the high cost and invasive nature of the required surgical procedures. Brain implants typically necessitate complex neurosurgeries, such as open-skull craniotomies, which carry substantial health risks including infection, hemorrhage, and stroke. These dangers, combined with the prohibitive costs of the implantable devices and the need for long-term post-operative care, create a high barrier to entry. Consequently, patients and healthcare providers often limit these interventions to only the most severe cases where pharmaceutical treatments have failed, thereby reducing the potential addressable market.

This restrictive dynamic is evident in current adoption statistics. According to the American Association of Neurological Surgeons, deep brain stimulation was used to treat over 160,000 people globally for various neurological conditions in 2024. When compared to the millions of patients suffering from debilitating movement disorders, this adoption figure is disproportionately low. The stark contrast between the vast eligible patient population and the limited number of treated individuals highlights how these financial and procedural challenges effectively stifle the broader expansion of the sector.

Market Trends

The Emergence of Speech and Motor Restoration via Direct Neural Control is fundamentally reshaping the market landscape by evolving neuroprosthetics from basic cursor control to the reconstruction of rapid, naturalistic communication. This trend is driven by advanced algorithms that can decode neural activity into fluent speech with a speed and accuracy that rivals natural conversation, overcoming the significant latency issues found in earlier generations. A major validation of this capability was reported recently; according to The Associated Press in April 2025, in an article titled 'A stroke survivor speaks again with the help of an experimental brain-computer implant,' a new brain-computer interface system successfully decoded the neural signals of a paralyzed stroke survivor into speech at a rate of approximately 91 words per minute, significantly surpassing previous standards.

In parallel, the Adoption of Closed-Loop Adaptive Deep Brain Stimulation Systems is redefining the standard of care for movement disorders by replacing static, continuous stimulation with dynamic, responsive therapy. These next-generation implants employ integrated sensing technology to monitor local field potentials and automatically modulate electrical delivery in real-time, thereby optimizing clinical efficacy while minimizing adverse side effects. This shift toward personalized bio-electronic medicine reached a critical commercial milestone; according to MedTech Dive in February 2025, in the article 'Medtronic gains FDA OK for self-adjusting DBS system for Parkinson's,' Medtronic received FDA approval for its BrainSense Adaptive DBS device, marking the first regulatory authorization for a system that self-adjusts therapy based on detected brain activity.

Key Market Players

  • Medtronic plc
  • Boston Scientific Corporation
  • Abbott Laboratories
  • NeuroPace, Inc.
  • LivaNova plc
  • Aleva Neurotherapeutics SA
  • Neuralink Corporation
  • Synchron, Inc.
  • Paradromics Inc.
  • Blackrock Neurotech

Report Scope

In this report, the Global Brain Implants Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Brain Implants Market, By Product Type

  • Deep Brain Stimulators
  • Spinal Cord Stimulators
  • Vagus Nerve Stimulators

Brain Implants Market, By Application

  • Chronic Pain
  • Epilepsy
  • Parkinson's Disease
  • Depression
  • Essential Tremor
  • Alzheimer's Disease

Brain Implants Market, By End User

  • Hospitals & Clinics
  • Ambulatory Surgery Centers
  • Others

Brain Implants Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Brain Implants Market.

Available Customizations:

Global Brain Implants Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Brain Implants Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (Deep Brain Stimulators, Spinal Cord Stimulators, Vagus Nerve Stimulators)
    • 5.2.2. By Application (Chronic Pain, Epilepsy, Parkinson's Disease, Depression, Essential Tremor, Alzheimer's Disease)
    • 5.2.3. By End User (Hospitals & Clinics, Ambulatory Surgery Centers, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Brain Implants Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By Application
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Brain Implants Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Brain Implants Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Brain Implants Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End User

7. Europe Brain Implants Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Application
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Brain Implants Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. France Brain Implants Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Brain Implants Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Brain Implants Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Brain Implants Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End User

8. Asia Pacific Brain Implants Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Brain Implants Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. India Brain Implants Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Brain Implants Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Brain Implants Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Brain Implants Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. Middle East & Africa Brain Implants Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Brain Implants Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. UAE Brain Implants Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. South Africa Brain Implants Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User

10. South America Brain Implants Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Application
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Brain Implants Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Colombia Brain Implants Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. Argentina Brain Implants Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Brain Implants Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Medtronic plc
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Boston Scientific Corporation
  • 15.3. Abbott Laboratories
  • 15.4. NeuroPace, Inc.
  • 15.5. LivaNova plc
  • 15.6. Aleva Neurotherapeutics SA
  • 15.7. Neuralink Corporation
  • 15.8. Synchron, Inc.
  • 15.9. Paradromics Inc.
  • 15.10. Blackrock Neurotech

16. Strategic Recommendations

17. About Us & Disclaimer